Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002336
Status:
COMPLETED
Last Update Posted:
2015-01-16
First Post:
1999-11-02
Brief Title:
The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex MAC Infection in HIV-Infected Patients
Sponsor:
Abbott
Organization:
Abbott
Study Overview
Official Title:
A Prospective Randomized Double-Blind Multicenter Placebo-Controlled Study of the Safety and Efficacy of Clarithromycin for the Prevention of Disseminated Mycobacterium Avium Complex MAC Infection in HIV-Infected Patients With CD4 Counts 100 Cellsmm3
Status:
COMPLETED
Status Verified Date:
2009-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine whether clarithromycin is safe and effective in preventing disseminated Mycobacterium avium Complex in HIV-infected patients with CD4 counts 100 cellsmm3
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| M91-561 | None | None | None |